Literature DB >> 15948185

Microarrays and expression profiling in microglia research and in inflammatory brain disorders.

Peter J Gebicke-Haerter1.   

Abstract

Expression profiling by using microarrays is a powerful tool for investigating transcriptional changes in a variety of diseases. In this survey, microarray data selected from the literature from in vivo and in vitro studies are scrutinized to find differentially expressed genes in common within specific inflammatory conditions in brain or microglial cell cultures, if there are at least two independent investigations available. Viral encephalitis, multiple sclerosis, epileptic seizures, ischemic lesions, and traumatic brain injury are the disorders covered. Moreover, by taking into account expression data obtained from cultured microglia, two examples are presented of how one can deal (or should not deal) with lists of candidate genes showing up in these kinds of studies without sophisticated software programs. Finally, some general remarks are made about pivotal issues when beginning to use microarray technology. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15948185     DOI: 10.1002/jnr.20479

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  9 in total

1.  Specific glial functions contribute to schizophrenia susceptibility.

Authors:  Andrea Goudriaan; Christiaan de Leeuw; Stephan Ripke; Christina M Hultman; Pamela Sklar; Patrick F Sullivan; August B Smit; Danielle Posthuma; Mark H G Verheijen
Journal:  Schizophr Bull       Date:  2013-08-16       Impact factor: 9.306

2.  Acyl-2-aminobenzimidazoles: a novel class of neuroprotective agents targeting mGluR5.

Authors:  Xinhua He; Sirish K Lakkaraju; Marie Hanscom; Zaorui Zhao; Junfang Wu; Bogdan Stoica; Alexander D MacKerell; Alan I Faden; Fengtian Xue
Journal:  Bioorg Med Chem       Date:  2015-03-06       Impact factor: 3.641

3.  The genomic profile of the cerebral cortex after closed head injury in mice: effects of minocycline.

Authors:  Peter J Crack; Jodee Gould; Nicole Bye; Shelley Ross; Uğur Ali; Mark D Habgood; Cristina Morganti-Kossman; Norman R Saunders; Paul J Hertzog
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

4.  Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders.

Authors:  Alejandra Borjabad; Susan Morgello; Wei Chao; Seon-Young Kim; Andrew I Brooks; Jacinta Murray; Mary Jane Potash; David J Volsky
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

5.  Negative regulation of glial engulfment activity by Draper terminates glial responses to axon injury.

Authors:  Mary A Logan; Rachel Hackett; Johnna Doherty; Amy Sheehan; Sean D Speese; Marc R Freeman
Journal:  Nat Neurosci       Date:  2012-03-18       Impact factor: 24.884

6.  Benzimidazole Containing Acetamide Derivatives Attenuate Neuroinflammation and Oxidative Stress in Ethanol-Induced Neurodegeneration.

Authors:  Muhammad Imran; Lina Tariq Al Kury; Humaira Nadeem; Fawad Ali Shah; Muzaffar Abbas; Shagufta Naz; Arif-Ullah Khan; Shupeng Li
Journal:  Biomolecules       Date:  2020-01-08

7.  The lack of expression of the peripheral benzodiazepine receptor characterises microglial response in anaplastic astrocytomas.

Authors:  Shigetoshi Takaya; Kazuo Hashikawa; Federico E Turkheimer; Nicholas Mottram; Manuel Deprez; Koichi Ishizu; Hidekazu Kawashima; Haruhiko Akiyama; Hidenao Fukuyama; Richard B Banati; Federico Roncaroli
Journal:  J Neurooncol       Date:  2007-05-23       Impact factor: 4.130

Review 8.  Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders.

Authors:  Alejandra Borjabad; Andrew I Brooks; David J Volsky
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-21       Impact factor: 7.285

9.  Microarray analysis in B cells among siblings with/without MS - role for transcription factor TCF2.

Authors:  Jagannadha R Avasarala; Sridar V Chittur; Ajish D George; John A Tine
Journal:  BMC Med Genomics       Date:  2008-01-31       Impact factor: 3.063

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.